Clinical Trials on Healthy Eating in Australia

Total 467 results

Spero Therapeutics
CPR Pharma Services Pty Ltd, Australia

Completed

A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of SPR741 in Healthy Volunteers

Healthy Volunteers

Australia
Actinogen Medical
Novotech (Australia) Pty Limited; Linear Clinical Research

Completed

Phase I MAD, Fed-Fasted, CSF Study of UE2343 in Healthy Subjects

Healthy Volunteers

Australia
Zhejiang Vimgreen Pharmaceuticals, Ltd.
Tigermed Consulting Co., Ltd

Recruiting

A Phase I Study of Single and Multiple Doses of VG290131 in Healthy Subjects

Healthy Volunteers

Australia
XWPharma

Completed

Safety, Tolerability and Pharmacokinetics of XW10508 Immediate and Modified Release Formulations in Healthy Adults

Healthy Volunteers

Australia
Atridia Pty Ltd.

Completed

A Trial of SHR8735 in Healthy Subjects

Healthy Volunteers

Australia
Concert Pharmaceuticals

Completed

A Study to Compare the Safety, Tolerability, and Pharmacokinetics of CTP-692 Versus D-serine in Healthy Volunteers

Healthy Volunteers

Australia
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Blood Collection for Use in Serological Assay Development From Healthy Adult Volunteers

Healthy

Australia
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Duration of Immunity in Healthy Adult Volunteers Who Completed Study 6108A1-500

Healthy

Australia
Auzone Biological Technology Pty Ltd
TIGERMED AUSTRALIA PTY LIMITED; CMAX Clinical Research Pty Ltd

Completed

A Study of TTYP01 in Healthy Adult Subjects

Healthy Adult Subjects

Australia
Galera Therapeutics, Inc.
Syneos Health

Completed

A Study Designed to Compare the Safety and Pharmacokinetics of Intravenously Administered Superoxide Dismutase Mimetic GC4711 and GC4419 in Healthy Volunteers

Healthy | Healthy Volunteers

Australia
Galera Therapeutics, Inc.
Syneos Health

Completed

A Phase 1, Randomized, Placebo-and Positive-Controlled Crossover Study to Determine the Effect of Single-Dose GC4419 on QTc Interval in Healthy Volunteers

Healthy | Healthy Volunteers

Australia
Dren Bio
Novotech

Recruiting

A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DR-0201 in Healthy Adult Volunteers

Healthy Adult Volunteers

Australia
Lyndra Inc.

Completed

Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules in Healthy Adults

Healthy | Gastric Retention

Australia
Celltrion

Completed

To Compare the PK and Safety of Omalizumab (CT-P39, EU-approved Xolair, and US-licensed Xolair) in Healthy Subjects

Healthy

Australia
Cochlear
Avania

Not yet recruiting

Clinical Performance of the Osia 3 Sound Processor Compared With the Osia 2 Sound Processor in Adult Osia Implant Users (RECONNECT)

Hearing Loss, Conductive | Hearing Loss, Mixed Conductive-Sensorineural

Australia
Cochlear
Avania

Completed

Acceptance and Performance of the CP1170 Sound Processor in Experienced Adult Cochlear Implant Recipients (POLAR) (POLAR)

Hearing Impairment

Australia
Changchun GeneScience Pharmaceutical Co., Ltd.
Syneos Health

Recruiting

A Study to Assess Safety and Tolerability of GS1-144 in Healthy Volunteers

Vasomotor Symptoms | Adult Healthy Volunteers

Australia
Cochlear

Completed

An Actual Use, Open-label Study Assessing Usability of Remote Assist to Program Cochlear Implant Recipients (RAL)

Hearing Loss, Sensorineural | Hearing Loss, Bilateral

Australia
Cochlear
Avania

Completed

CP1150 Sound Processor Speech Perception Compared With the Next Generation of Signal Processing Technology

Hearing Impairment, Sensorineural

Australia
Swinburne University of Technology

Completed

Cognition Effects of Hearing Aids and Auditory Training in Older Age

Hearing Loss, Sensorineural

Australia
The George Institute
The University of New South Wales

Recruiting

Trial of Enhanced Neurostimulation for Anorexia (TRENA)

Anorexia Nervosa

Australia
Cochlear

Completed

Clinical Evaluation of a Cochlear Implant System

Sensorineural Hearing Loss

Australia
Terran Biosciences Australia Pty Ltd

Recruiting

A Study of Idazoxan in Healthy Participants

Healthy

Australia
The Bionics Institute of Australia

Not yet recruiting

EarGenie MVP Performance Evaluation

Hearing Impaired Children

Australia
The Bionics Institute of Australia

Recruiting

Improving Early Intervention in Hearing Impaired Children Using Functional Near-Infrared Spectroscopy (fNIRS)

Hearing Impairment

Australia
SIMR (Australia) Biotech Pty Ltd.

Completed

A Study to Assess the Pharmacokinetics and Food Effect of SR419 in Healthy Subjects

Healthy

Australia
CSL Behring

Completed

Pharmacokinetics and Safety of Subcutaneous CSL324 in Healthy Japanese and White Subjects

Healthy

Australia
Haisco Pharmaceutical Group Co., Ltd.
Haisco Pharmaceutical(Australia) Pty Ltd.

Completed

A Study of Safety, Tolerability, and Pharmacokinetics of Single Ascending Dosed of HSK31858 in Healthy Volunteers

Healthy

Australia
EnnovaBio Australia Pharmaceuticals Pty Ltd

Completed

A First-in-human Single Ascending Dose/Multiple Ascending Dose Study of ENN0403 in Healthy Subjects

Healthy

Australia
Alexion Pharmaceuticals

Completed

Study of Danicopan in Participants of Japanese Descent

Healthy

Australia
Regeneron Pharmaceuticals
Sanofi

Completed

Safety and Tolerability Study of REGN846 (SAR302352) in Healthy Volunteers

Healthy

Australia
Neuren Pharmaceuticals Limited

Completed

To Evaluate the Safety, Tolerability and Pharmacokinetics of Oral NNZ-2591 in Healthy Volunteers

Healthy Volunteers

Australia
Hoffmann-La Roche

Completed

A Study in Healthy Male Subjects to Investigate the Comparability of Pharmacokinetics of the Fixed-Dose Combination of Pertuzumab and Trastuzumab Administered Subcutaneously Using a Handheld Syringe or Using the On-Body Delivery System

Healthy Male Subjects

Australia, New Zealand
ILIAS Biologics Inc.

Completed

A Study to Evaluate the Safety and Tolerability of ILB-202

Healthy

Australia
Amazentis SA
Australian Catholic University

Completed

Effects of Mitopure (Urolithin A) on Skeletal Muscle Function, Iron Metabolism and Endurance Performance (ENDURO)

Healthy

Australia
Janssen Research & Development, LLC

Completed

A Study of JNJ-77474462 in Healthy Participants

Healthy

Australia
Janssen Research & Development, LLC

Completed

A Study of JNJ-77474462 (Bermekimab) in Healthy Participants of Japanese Descent Following Administration of Single Ascending Subcutaneous Doses

Healthy

Australia
AnnJi Pharmaceutical Co., Ltd.

Completed

A Study to Investigate the Safety, Tolerability, Pharmacokinetics of ALZ002 DS in Healthy Volunteers

Healthy

Australia
Sichuan Haisco Pharmaceutical Group Co., Ltd

Completed

Safety, Tolerability and Pharmacokinetics of FTP-198 in Healthy Australian Volunteers

Healthy

Australia
Allakos Inc.

Completed

Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AK002 in Healthy Participants

Healthy

Australia
Prestige Biopharma Limited

Completed

A Study to Demonstrate the Equivalent Pharmacokinetic Properties of a Single Intravenous Dose of HD201 and EU-Herceptin® and US-Herceptin® in Healthy Male Subjects (TROIKA-1)

Healthy Volunteers

Australia
RANI Therapeutics

Completed

Study Evaluating PK of PTH Administered Orally Via RaniPill™ Capsule

Healthy Volunteers

Australia
Principia Biopharma, a Sanofi Company

Completed

Food Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy Participants

Healthy Volunteers

Australia
Chengdu SciMount Pharmatech Co., Ltd.

Completed

A Phase 1 Study of SMP-100 in Normal Healthy Volunteers

Healthy Volunteers

Australia
Protagonist Therapeutics, Inc.

Completed

Pharmacokinetics of PN-235 in Healthy Volunteers

Healthy Volunteers

Australia
Angion Biomedica Corp

Completed

ANG-3070 in Healthy Adult Participants

Healthy Volunteers

Australia
Galera Therapeutics, Inc.

Completed

A Phase 1 Study of the Safety and Pharmacokinetics of GC4711 (Oral Capsule) Compared to GC4419 (IV Infusion) and GC4711 (IV Infusion) in Healthy Volunteers

Healthy Volunteers

Australia
Regeneron Pharmaceuticals

Completed

Intravenous/Subcutaneous FIH Study of REGN1154 in Healthy Volunteers

Healthy Volunteers

Australia
Suzhou Ribo Life Science Co. Ltd.

Recruiting

A Single Ascending Doses Phase I Study to Evaluate the Safety and Pharmacokinetics of RBD4059 in Healthy Subjects

Healthy Volunteers

Australia
Amckaus PTY LTD.

Recruiting

Aom0319 SAD Study in Healthy Subjects

Healthy Volunteers

Australia

3

Subscribe